This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing MT
Icu Medical Insider Sold Shares Worth $4,386,155, According to a Recent SEC Filing MT
ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director CI
Icu Medical Insider Sold Shares Worth $1,458,090, According to a Recent SEC Filing MT
Transcript : ICU Medical, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 07:30 AM
Smiths Group Confirms $88 Million Sale of ICU Medical Stake MT
ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee CI
An unknown buyer completed the acquisition of 3.44% stake in ICU Medical, Inc. (NasdaqGS : ICUI) from Smiths Group International Holdings Ltd. for $88.042 million. CI
KeyBanc Adjusts Price Target on ICU Medical to $136 From $134, Maintains Overweight Rating MT
ICU Medical's Q4 Adjusted Earnings Decline While Revenue Increases; Sets 2024 Adjusted Profit Guidance MT
ICU Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : ICU Medical, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 Revenue $587.9M, vs. Street Est of $568.3M MT
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 EPS $1.57, vs. Street Est of $1.19 MT
ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
ICU Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
CL King Starts ICU Medical With Buy Rating, $110 Price Target MT
Icu Medical Insider Sold Shares Worth $152,196, According to a Recent SEC Filing MT
ICU Medical, Inc.(NasdaqGS:ICUI) added to S&P 600 Health Care CI
ICU Medical, Inc.(NasdaqGS:ICUI) added to S&P 600 CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 Health Care CI
ICU Medical, Inc.(NasdaqGS:ICUI) dropped from S&P 400 CI
Sector Update: Financial Stocks Edge Higher Late Afternoon MT
Sector Update: Financial Stocks Higher Tuesday Afternoon MT
Chart ICU Medical, Inc.
More charts
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
95.77 USD
Average target price
142.2 USD
Spread / Average Target
+48.53%
Consensus
  1. Stock Market
  2. Equities
  3. ICUI Stock
  4. News ICU Medical, Inc.
  5. Carlyle Group to Replace ICU Medical in S&P MidCap 400 Index